This has been observed in autoimmune disease, where depleting PD-1+ autoreactive T cells in mice with type I diabetes or autoimmune encephalomyelitis led to delayed disease onset and improvement of symptoms (60). This evidence concerns the gene PDCD1 and autoimmune disease.